ATC Group: A01AD02 Benzydamine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A01AD02 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Stomatological preparations
3
Stomatological preparations
4
Other agents for local oral treatment
5
A01AD02
Benzydamine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
9 mg

Active ingredients in A01AD02

Active Ingredient
Description

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.

Medicines in this ATC group

Drug
Countries

Australia Cyprus Hong Kong Ireland New Zealand ...

Lithuania

Finland

Canada Hong Kong

Austria Lithuania Poland Spain

Lithuania

Poland

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Monograph (SPM)
CA